Left Atrial Appendage Closure Devices Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
The left atrial appendage closure devices market, owing to increasing prevalence of atrial fibrillation and ongoing technological advancements is projected to register a period of remunerative growth over the coming years. The left atrial appendage is a small sac in the shape of an ear inside the muscle wall of the left atrium in the heart. In the case of normal hearts, the heart typically contracts with the heartbeats, and the blood in the left atrium and left atrial appendage is squeezed into the left ventricle out of the left atrium. However, that is not the case with AF patients, here the electrical impulses that are responsible to control the heartbeat do not travel in normal manner through the heart. These impulses fire simultaneously in a fast and chaotic manner, not giving the heart the heart enough time to push the blood into the ventricles.
Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3960
With rising prevalence of AF, key industry players are increasingly concentrating on consolidating their position in the market by frequently innovating the product offerings, partnerships, mergers, and acquisitions, R&D, among others. Citing an instance, on 6th August 2020, Conformal Medical Inc., a leading medical device company, reportedly announced that it has secured approximately $85 million in Series C financing round to support its U.S. pivotal trial of its new CLAAS device, Conformal’s next generation transcatheter LAA closure occlude for atrial fibrillation patients. This left atrial appendage occlusion allows AF patients to be relieved from the life-long anticoagulation therapy.
The surgical procedure segment is likely to grow at a rate of around 27% by the end of the estimated timeframe. Surgical treatment of the LAA (left atrial appendage) has increased since the last few years. The most crucial complication of AF (atrial fibrillation) is a cerebral cardioembolic stroke. In fact, the left atrial appendage is the anatomical source of the embolism, in several patients with AF. Various surgical techniques for occluding the left atrial appendage utilizing several devices have been developed with different chances of success. These factors would fuel the segment share over the coming years.
The epicardial devices segment is estimated to grow by approximately 26.4% over the forecast timeframe. Devices specifically designed for excluding the left atrial appendage are applied from the exterior using epicardial devices. These devices are easy to use and enables adjusting of position of the clip after being deployed, making it much more convenient for the patient.
Moreover, these devices are much more preferred in comparison to endocardial devices, since endocardial devices usually do not sit well inside the LAAs with abnormal morphologies. These factors will drive the segmental growth across healthcare sector.
In 2019, the left atrial appendage closure devices market in Latin America was valued approximately $9.1 million and is likely to grow at around 24% over the forthcoming time period. The rising prevalence of atrial fibrillation across the region would fuel the demand for LAA closure devices in the region. The increasing number of AF across the region is due to poor control of main risk factors like hypertension and an ageing population. These factors will create favorable growth avenues for the LAA closure devices industry in the region.
Meanwhile, in 2019, the left atrial appendage closure devices market in Middle East & Africa was valued approximately $7.5 million and is anticipated to witness a CAGR of around 23% through the forecast time period. Booming healthcare sector with modern hospital complexes, integration of hi-tech equipment in the healthcare infrastructure, and presence of a well-qualified medical workforce across Middle East will greatly contribute to the market growth.
Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/left-atrial-appendage-closure-devices-market
Partial Chapter of the Table of Content
Chapter 4. Left Atrial Appendage Closure Devices Market, By Product
4.1. Key segment trends
4.2. Endocardial LAA closure devices
4.2.1. Market size, by region, 2015 – 2026 (USD Million)
4.2.2. Market size, by region, 2015 – 2026 (Units)
4.3. Epicardial LAA closure devices
4.3.1. Market size, by region, 2015 – 2026 (USD Million)
4.3.2. Market size, by region, 2015 – 2026 (Units)
Chapter 5. Left Atrial Appendage Closure Devices Market, By Procedure
5.1. Key segment trends
5.2.1. Market size, by region, 2015 – 2026 (USD Million)
5.2.2. Market size, by region, 2015 – 2026 (Units)
5.3.1. Market size, by region, 2015 – 2026 (USD Million)
5.3.2. Market size, by region, 2015 – 2026 (Units)